Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition-Reference-Cited by-同舟云学术

Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition

Published:2011-02-10 Issue:4 Volume:102 Page:858-865
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Toi Masakazu,Saji Shigehira,Masuda Norikazu,Kuroi Katsumasa,Sato Nobuaki,Takei Hiroyuki,Yamamoto Yutaka,Ohno Shinji,Yamashita Hiroko,Hisamatsu Kazufumi,Aogi Kenjiro,Iwata Hiroji,Takada Masahiro,Ueno Takayuki,Saji Shigetoyo,Chanplakorn Niramol,Suzuki Takashi,Sasano Hironobu

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2011.01867.x/fullpdf

Reference25 articles.

1. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

2. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

3. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902;van der Hage;J Clin Oncol,2001

4. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003

5. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer;Expert Review of Anticancer Therapy;2023-01-02

2. Prediction of Ki‐67 of Invasive Ductal Breast Cancer Based on Ultrasound Radiomics Nomogram;Journal of Ultrasound in Medicine;2022-07-19

3. Breast cancer management in 2021: A primer for the obstetrics and gynecology;Best Practice & Research Clinical Obstetrics & Gynaecology;2022-06

4. A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry;Breast Cancer Research and Treatment;2020-07-25

5. Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer;Chinese Clinical Oncology;2020-06